/
Stock
/
/
APIChangelogInfo

VERTEX PHARMACEUTICALS

Trade VRTX
VRTX Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-05-21
2025-05-21
LR 2019 BENEFIT TRUST
S - Sale
-170
$447.00
-75,990
1
$116.96B
2025-05-21
2025-05-21
SR 2019 BENEFIT TRUST
S - Sale
-170
$447.00
-75,990
1
$116.96B
2025-05-21
2025-05-21
LR 2019 BENEFIT TRUST
S - Sale
-170
$447.00
-75,990
1
$116.96B
2025-05-21
2025-05-21
SR 2019 BENEFIT TRUST
S - Sale
-170
$447.00
-75,990
1
$116.96B
2025-05-15
2025-05-19
ALTSHULER DAVID
EVP, Chief Scientific Officer
S - Sale
Common Stock
-52
$425.00
-22,100
1
$116.96B
2025-05-13
2025-05-15
ARBUCKLE STUART
EVP, COO
A - Grant
Common Stock
37,622
$0.00
1
$116.96B
2025-05-02
2025-05-05
BHATIA SANGEETA
S - Sale
Common Stock
-400
$506.00
-202K
1
$116.96B
2025-05-01
2025-05-05
GARBER ALAN
A - Grant
Common Stock
398
$0.00
1
$116.96B
2025-05-01
2025-05-05
UPADHYAY SUKETU
D - Sale to Issuer
Common Stock
-1,001
1
$116.96B
2025-05-01
2025-05-05
THORNBERRY NANCY
A - Grant
Common Stock
398
$0.00
1
$116.96B
2025-05-01
2025-05-05
LAGARDE MICHEL
A - Grant
Stock Option (Right to Buy)
2,398
$0.00
1
$116.96B
2025-05-01
2025-05-05
SCHNEIDER JENNIFER
A - Grant
Common Stock
796
$0.00
1
$116.96B
2025-05-01
2025-05-05
SACHS BRUCE
A - Grant
Stock Option (Right to Buy)
2,398
$0.00
1
$116.96B
2025-05-01
2025-05-05
BHATIA SANGEETA
A - Grant
Common Stock
796
$0.00
1
$116.96B
2025-05-01
2025-05-05
LAGARDE MICHEL
A - Grant
Stock Option (Right to Buy)
2,398
$0.00
1
$116.96B
2025-05-01
2025-05-05
UPADHYAY SUKETU
A - Grant
Common Stock
796
$0.00
1
$116.96B
2025-05-01
2025-05-05
GARBER ALAN
A - Grant
Common Stock
398
$0.00
1
$116.96B
2025-05-01
2025-05-05
MCKENZIE DIANA
A - Grant
Common Stock
796
$0.00
1
$116.96B
2025-05-01
2025-05-05
UPADHYAY SUKETU
A - Grant
Deferred Stock Units
1,001
1
$116.96B
2025-05-01
2025-05-05
GARBER ALAN
A - Grant
Stock Option (Right to Buy)
1,199
$0.00
1
$116.96B
2025-05-01
2025-05-05
GARBER ALAN
A - Grant
Stock Option (Right to Buy)
1,199
$0.00
1
$116.96B
2025-05-01
2025-05-05
MCKENZIE DIANA
A - Grant
Deferred Stock Units
1,001
1
$116.96B
2025-05-01
2025-05-05
SACHS BRUCE
A - Grant
Stock Option (Right to Buy)
2,398
$0.00
1
$116.96B
2025-05-01
2025-05-05
UPADHYAY SUKETU
A - Grant
Deferred Stock Units
1,001
1
$116.96B
2025-05-01
2025-05-05
UPADHYAY SUKETU
D - Sale to Issuer
Common Stock
-1,001
1
$116.96B
2025-05-01
2025-05-05
THORNBERRY NANCY
A - Grant
Stock Option (Right to Buy)
1,199
$0.00
1
$116.96B
2025-05-01
2025-05-05
SCHNEIDER JENNIFER
A - Grant
Common Stock
796
$0.00
1
$116.96B
2025-05-01
2025-05-05
MCKENZIE DIANA
A - Grant
Common Stock
796
$0.00
1
$116.96B
2025-05-01
2025-05-05
MCKENZIE DIANA
A - Grant
Deferred Stock Units
1,001
1
$116.96B
2025-05-01
2025-05-05
THORNBERRY NANCY
A - Grant
Common Stock
398
$0.00
1
$116.96B
2025-05-01
2025-05-05
MCKENZIE DIANA
D - Sale to Issuer
Common Stock
-1,001
1
$116.96B
2025-05-01
2025-05-05
BHATIA SANGEETA
A - Grant
Common Stock
796
$0.00
1
$116.96B
2025-05-01
2025-05-05
UPADHYAY SUKETU
A - Grant
Common Stock
796
$0.00
1
$116.96B
2025-05-01
2025-05-05
THORNBERRY NANCY
A - Grant
Stock Option (Right to Buy)
1,199
$0.00
1
$116.96B
2025-05-01
2025-05-05
MCKENZIE DIANA
D - Sale to Issuer
Common Stock
-1,001
1
$116.96B
2025-05-01
2025-05-05
CARNEY LLOYD
A - Grant
Common Stock
796
$0.00
1
$116.96B
2025-05-01
2025-05-05
CARNEY LLOYD
A - Grant
Common Stock
796
$0.00
1
$116.96B
2025-04-15
2025-04-17
SACHS BRUCE
A - Grant
Deferred Stock Units
95
$498.00
47,310
1
$116.96B
2025-04-15
2025-04-17
UPADHYAY SUKETU
A - Grant
Deferred Stock Units
71
$498.00
35,358
1
$116.96B
2025-03-13
2025-03-17
ALTSHULER DAVID
EVP, Chief Scientific Officer
S - Sale
Common Stock
-3,231
$510.00
-1.65M
1
$116.96B
2025-03-10
2025-03-12
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
S - Sale
Common Stock
-3,242
$500.00
-1.62M
1
$116.96B
2025-03-10
2025-03-12
WAGNER CHARLES JR
EVP & Chief Financial Officer
S - Sale
Common Stock
-3,298
$500.00
-1.65M
1
$116.96B
2025-03-10
2025-03-12
ALTSHULER DAVID
EVP, Chief Scientific Officer
S - Sale
Common Stock
-3,231
$500.00
-1.62M
1
$116.96B
2025-03-04
2025-03-06
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
S - Sale
Common Stock
-4,058
$485.00
-1.97M
1
$116.96B
2025-03-03
2025-03-05
ALTSHULER DAVID
EVP, Chief Scientific Officer
S - Sale
Common Stock
-3,231
$490.00
-1.58M
1
$116.96B
2025-02-27
2025-02-28
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
S - Sale
Common Stock
-530
$475.00
-252K
1
$116.96B
2025-02-27
2025-02-28
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
S - Sale
Common Stock
-2,650
$475.00
-1.26M
1
$116.96B
2025-02-27
2025-02-28
ALTSHULER DAVID
EVP, Chief Scientific Officer
S - Sale
Common Stock
-1,272
$480.00
-611K
1
$116.96B
2025-02-26
2025-02-28
ARBUCKLE STUART
EVP, COO
F - Tax
Common Stock
-7,071
$480.00
-3.39M
1
$116.96B
2025-02-26
2025-02-28
WAGNER CHARLES JR
EVP & Chief Financial Officer
F - Tax
Common Stock
-4,962
$480.00
-2.38M
1
$116.96B
2025-02-26
2025-02-28
ALTSHULER DAVID
EVP, Chief Scientific Officer
F - Tax
Common Stock
-5,954
$480.00
-2.86M
1
$116.96B
2025-02-26
2025-02-28
SACHDEV AMIT
EVP Chief Patient & Ext Af Off
F - Tax
Common Stock
-3,703
$480.00
-1.78M
1
$116.96B
2025-02-26
2025-02-28
KEWALRAMANI RESHMA
CEO & President
F - Tax
Common Stock
-14,079
$480.00
-6.76M
1
$116.96B
2025-02-26
2025-02-28
BOZIC CARMEN
EVP and CMO
F - Tax
Common Stock
-4,962
$480.00
-2.38M
1
$116.96B
2025-02-26
2025-02-28
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
F - Tax
Common Stock
-2,482
$480.00
-1.19M
1
$116.96B
2025-02-26
2025-02-28
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
F - Tax
Common Stock
-4,962
$480.00
-2.38M
1
$116.96B
2025-02-26
2025-02-28
AMBROSE KRISTEN
SVP & Chief Accounting Officer
F - Tax
Common Stock
-1,241
$480.00
-596K
1
$116.96B
2025-02-25
2025-02-26
ALTSHULER DAVID
EVP, Chief Scientific Officer
S - Sale
Common Stock
-848
$481.00
-408K
1
$116.96B
2025-02-25
2025-02-26
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
S - Sale
Common Stock
-354
$481.00
-170K
1
$116.96B
2025-02-25
2025-02-26
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
S - Sale
Common Stock
-1,767
$481.00
-850K
1
$116.96B
2025-02-25
2025-02-26
AMBROSE KRISTEN
SVP & Chief Accounting Officer
S - Sale
Common Stock
-884
$481.00
-425K
1
$116.96B
2025-02-24
2025-02-26
AMBROSE KRISTEN
SVP & Chief Accounting Officer
F - Tax
Common Stock
-828
$483.00
-400K
1
$116.96B
2025-02-24
2025-02-26
ARBUCKLE STUART
EVP, COO
F - Tax
Common Stock
-4,716
$483.00
-2.28M
1
$116.96B
2025-02-24
2025-02-26
ALTSHULER DAVID
EVP, Chief Scientific Officer
F - Tax
Common Stock
-3,971
$483.00
-1.92M
1
$116.96B
2025-02-24
2025-02-26
SACHDEV AMIT
EVP Chief Patient & Ext Af Off
F - Tax
Common Stock
-2,470
$483.00
-1.19M
1
$116.96B
2025-02-24
2025-02-26
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
F - Tax
Common Stock
-3,310
$483.00
-1.60M
1
$116.96B
2025-02-24
2025-02-26
BOZIC CARMEN
EVP and CMO
F - Tax
Common Stock
-3,310
$483.00
-1.60M
1
$116.96B
2025-02-24
2025-02-26
WAGNER CHARLES JR
EVP & Chief Financial Officer
F - Tax
Common Stock
-3,310
$483.00
-1.60M
1
$116.96B
2025-02-24
2025-02-26
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
F - Tax
Common Stock
-1,656
$483.00
-800K
1
$116.96B
2025-02-24
2025-02-26
KEWALRAMANI RESHMA
CEO & President
F - Tax
Common Stock
-9,386
$483.00
-4.53M
1
$116.96B
2025-02-20
2025-02-24
ALTSHULER DAVID
EVP, Chief Scientific Officer
S - Sale
Common Stock
-1,111
$480.00
-533K
1
$116.96B
2025-02-18
2025-02-19
BILLER JONATHAN
EVP and Chief Legal Officer
S - Sale
Common Stock
-1,657
$455.00
-754K
1
$116.96B
2025-02-18
2025-02-19
AMBROSE KRISTEN
SVP & Chief Accounting Officer
S - Sale
Common Stock
-671
$455.00
-305K
1
$116.96B
2025-02-18
2025-02-19
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
S - Sale
Common Stock
-244
$455.00
-111K
1
$116.96B
2025-02-14
2025-02-19
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
F - Tax
Common Stock
-2,293
$463.00
-1.06M
1
$116.96B
2025-02-14
2025-02-19
LEIDEN JEFFREY
Executive Chairman
F - Tax
Common Stock
-6,066
$463.00
-2.81M
1
$116.96B
2025-02-14
2025-02-19
BILLER JONATHAN
EVP and Chief Legal Officer
F - Tax
Common Stock
-1,504
$463.00
-696K
1
$116.96B
2025-02-14
2025-02-19
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
F - Tax
Common Stock
-1,529
$463.00
-708K
1
$116.96B
2025-02-14
2025-02-19
SACHDEV AMIT
EVP Chief Patient & Ext Af Off
F - Tax
Common Stock
-2,139
$463.00
-990K
1
$116.96B
2025-02-14
2025-02-19
KEWALRAMANI RESHMA
CEO & President
F - Tax
Common Stock
-6,553
$463.00
-3.03M
1
$116.96B
2025-02-14
2025-02-19
WAGNER CHARLES JR
EVP & Chief Financial Officer
F - Tax
Common Stock
-2,293
$463.00
-1.06M
1
$116.96B
2025-02-14
2025-02-19
BOZIC CARMEN
EVP and CMO
F - Tax
Common Stock
-1,912
$463.00
-885K
1
$116.96B
2025-02-14
2025-02-19
ARBUCKLE STUART
EVP, COO
F - Tax
Common Stock
-2,724
$463.00
-1.26M
1
$116.96B
2025-02-14
2025-02-19
AMBROSE KRISTEN
SVP & Chief Accounting Officer
F - Tax
Common Stock
-564
$463.00
-261K
1
$116.96B
2025-02-14
2025-02-19
ALTSHULER DAVID
EVP, Chief Scientific Officer
F - Tax
Common Stock
-2,293
$463.00
-1.06M
1
$116.96B
2025-02-13
2025-02-14
LEIDEN JEFFREY
Executive Chairman
F - Tax
Common Stock
-2,525
$451.00
-1.14M
1
$116.96B
2025-02-12
2025-02-14
ALTSHULER DAVID
EVP, Chief Scientific Officer
A - Grant
Common Stock
5,324
$0.00
1
$116.96B
2025-02-12
2025-02-14
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
A - Grant
Common Stock
6,211
$0.00
1
$116.96B
2025-02-12
2025-02-14
LEIDEN JEFFREY
Executive Chairman
A - Grant
Common Stock
7,209
$0.00
1
$116.96B
2025-02-12
2025-02-14
WAGNER CHARLES JR
EVP & Chief Financial Officer
A - Grant
Common Stock
6,655
$0.00
1
$116.96B
2025-02-12
2025-02-14
BOZIC CARMEN
EVP and CMO
A - Grant
Common Stock
5,546
$0.00
1
$116.96B
2025-02-12
2025-02-14
KEWALRAMANI RESHMA
CEO & President
A - Grant
Common Stock
19,015
$0.00
1
$116.96B
2025-02-12
2025-02-14
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
A - Grant
Common Stock
6,211
$0.00
1
$116.96B
2025-02-12
2025-02-14
SACHDEV AMIT
EVP Chief Patient & Ext Af Off
A - Grant
Common Stock
6,211
$0.00
1
$116.96B
2025-02-12
2025-02-14
BILLER JONATHAN
EVP and Chief Legal Officer
A - Grant
Common Stock
4,437
$0.00
1
$116.96B
2025-02-12
2025-02-14
ARBUCKLE STUART
EVP, COO
A - Grant
Common Stock
7,903
$0.00
1
$116.96B
2025-02-12
2025-02-14
AMBROSE KRISTEN
SVP & Chief Accounting Officer
A - Grant
Common Stock
2,080
$0.00
1
$116.96B
2025-02-11
2025-02-12
BILLER JONATHAN
EVP and Chief Legal Officer
S - Sale
Common Stock
-3,433
$460.00
-1.58M
1
$116.96B
2025-02-11
2025-02-12
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
S - Sale
Common Stock
-310
$460.00
-143K
1
$116.96B
2025-02-11
2025-02-12
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
S - Sale
Common Stock
-1,747
$460.00
-804K
1
$116.96B
2025-02-11
2025-02-12
AMBROSE KRISTEN
SVP & Chief Accounting Officer
S - Sale
Common Stock
-1,376
$460.00
-633K
1
$116.96B
2025-02-10
2025-02-12
KEWALRAMANI RESHMA
CEO & President
F - Tax
Common Stock
-8,300
$468.00
-3.88M
1
$116.96B
2025-02-10
2025-02-12
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
F - Tax
Common Stock
-2,143
$468.00
-1.00M
1
$116.96B
2025-02-10
2025-02-12
SACHDEV AMIT
EVP Chief Patient & Ext Af Off
F - Tax
Common Stock
-2,056
$468.00
-962K
1
$116.96B
2025-02-10
2025-02-12
BOZIC CARMEN
EVP and CMO
F - Tax
Common Stock
-2,142
$468.00
-1.00M
1
$116.96B
2025-02-10
2025-02-12
BILLER JONATHAN
EVP and Chief Legal Officer
F - Tax
Common Stock
-1,632
$468.00
-764K
1
$116.96B
2025-02-10
2025-02-12
ARBUCKLE STUART
EVP, COO
F - Tax
Common Stock
-3,220
$468.00
-1.51M
1
$116.96B
2025-02-10
2025-02-12
AMBROSE KRISTEN
SVP & Chief Accounting Officer
F - Tax
Common Stock
-591
$468.00
-277K
1
$116.96B
2025-02-10
2025-02-12
ALTSHULER DAVID
EVP, Chief Scientific Officer
F - Tax
Common Stock
-2,142
$468.00
-1.00M
1
$116.96B
2025-02-10
2025-02-12
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
F - Tax
Common Stock
-876
$468.00
-410K
1
$116.96B
2025-02-10
2025-02-12
WAGNER CHARLES JR
EVP & Chief Financial Officer
F - Tax
Common Stock
-2,649
$468.00
-1.24M
1
$116.96B
2025-02-04
2025-02-06
BOZIC CARMEN
EVP and CMO
A - Grant
Common Stock
16,190
$0.00
2
$116.96B
2025-02-04
2025-02-06
BILLER JONATHAN
EVP and Chief Legal Officer
A - Grant
Common Stock
4,744
$0.00
1
$116.96B
2025-02-04
2025-02-06
KEWALRAMANI RESHMA
CEO & President
A - Grant
Common Stock
49,446
$0.00
2
$116.96B
2025-02-04
2025-02-06
AMBROSE KRISTEN
SVP & Chief Accounting Officer
A - Grant
Common Stock
4,420
$0.00
2
$116.96B
2025-02-04
2025-02-06
BOZIC CARMEN
EVP and CMO
A - Grant
Common Stock
16,190
$0.00
2
$116.96B
2025-02-04
2025-02-06
ALTSHULER DAVID
EVP, Chief Scientific Officer
A - Grant
Common Stock
19,428
$0.00
2
$116.96B
2025-02-04
2025-02-06
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
A - Grant
Common Stock
9,876
$0.00
2
$116.96B
2025-02-04
2025-02-06
LEIDEN JEFFREY
Executive Chairman
A - Grant
Common Stock
15,414
$0.00
1
$116.96B
2025-02-04
2025-02-06
AMBROSE KRISTEN
SVP & Chief Accounting Officer
A - Grant
Common Stock
4,420
$0.00
2
$116.96B
2025-02-04
2025-02-06
ARBUCKLE STUART
EVP, COO
A - Grant
Common Stock
23,072
$0.00
2
$116.96B
2025-02-04
2025-02-06
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
A - Grant
Common Stock
9,876
$0.00
2
$116.96B
2025-02-04
2025-02-06
ARBUCKLE STUART
EVP, COO
A - Grant
Common Stock
23,072
$0.00
2
$116.96B
2025-02-04
2025-02-06
BILLER JONATHAN
EVP and Chief Legal Officer
A - Grant
Common Stock
4,744
$0.00
1
$116.96B
2025-02-04
2025-02-06
ALTSHULER DAVID
EVP, Chief Scientific Officer
A - Grant
Common Stock
19,428
$0.00
2
$116.96B
2025-02-04
2025-02-06
LEIDEN JEFFREY
Executive Chairman
A - Grant
Common Stock
15,414
$0.00
1
$116.96B
2025-02-04
2025-02-06
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
A - Grant
Common Stock
17,376
$0.00
2
$116.96B
2025-02-04
2025-02-06
SACHDEV AMIT
EVP Chief Patient & Ext Af Off
A - Grant
Common Stock
15,324
$0.00
2
$116.96B
2025-02-04
2025-02-06
KEWALRAMANI RESHMA
CEO & President
A - Grant
Common Stock
49,446
$0.00
2
$116.96B
2025-02-04
2025-02-06
SACHDEV AMIT
EVP Chief Patient & Ext Af Off
A - Grant
Common Stock
15,324
$0.00
2
$116.96B
2025-02-04
2025-02-06
WAGNER CHARLES JR
EVP & Chief Financial Officer
A - Grant
Common Stock
17,376
$0.00
2
$116.96B
2025-02-04
2025-02-06
WAGNER CHARLES JR
EVP & Chief Financial Officer
A - Grant
Common Stock
17,376
$0.00
2
$116.96B
2025-02-04
2025-02-06
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
A - Grant
Common Stock
17,376
$0.00
2
$116.96B
2025-01-15
2025-01-17
SACHS BRUCE
A - Grant
Deferred Stock Units
111
$420.00
46,620
1
$116.96B
2024-11-15
2024-11-19
ALTSHULER DAVID
EVP, Chief Scientific Officer
S - Sale
Common Stock
-15
$479.00
-7,185
1
$116.96B
2024-11-11
2024-11-13
WAGNER CHARLES JR
EVP & Chief Financial Officer
S - Sale
Common Stock
-3,000
$518.00
-1.55M
1
$116.96B
2024-11-08
2024-11-12
KEWALRAMANI RESHMA
CEO & President
S - Sale
Common Stock
-15,198
$515.00
-7.83M
1
$116.96B
2024-10-15
2024-10-17
SACHS BRUCE
A - Grant
Deferred Stock Units
90
$484.00
43,560
1
$116.96B
2024-10-02
2024-10-03
BILLER JONATHAN
EVP and Chief Legal Officer
S - Sale
Common Stock
-999
$462.00
-462K
1
$116.96B
2024-10-01
2024-10-03
BILLER JONATHAN
EVP and Chief Legal Officer
F - Tax
Common Stock
-630
$467.00
-294K
1
$116.96B
2024-08-30
2024-09-04
BHATIA SANGEETA
S - Sale
Common Stock
-646
$500.00
-323K
1
$116.96B
2024-08-30
2024-09-04
LEIDEN JEFFREY
Executive Chairman
S - Sale
Common Stock
-3,784
$499.00
-1.89M
1
$116.96B
2024-08-30
2024-09-04
BHATIA SANGEETA
M - Exercise
Common Stock
646
$153.00
98,838
1
$116.96B
2024-08-30
2024-09-04
BHATIA SANGEETA
M - Exercise
Stock Option (Right to Buy)
-646
$0.00
1
$116.96B
2024-08-08
2024-08-12
BHATIA SANGEETA
M - Exercise
Common Stock
1,292
$153.00
198K
1
$116.96B
2024-08-08
2024-08-12
BHATIA SANGEETA
M - Exercise
Stock Option (Right to Buy)
-1,292
$0.00
1
$116.96B
2024-08-08
2024-08-12
BHATIA SANGEETA
S - Sale
Common Stock
-1,292
$466.00
-602K
1
$116.96B
2024-08-07
2024-08-08
BOZIC CARMEN
EVP and CMO
S - Sale
Common Stock
-2,280
$477.00
-1.09M
1
$116.96B
2024-08-01
2024-08-02
SACHS BRUCE
S - Sale
Common Stock
-5,295
$508.00
-2.69M
1
$116.96B
2024-08-01
2024-08-02
SACHS BRUCE
M - Exercise
Common Stock
5,295
$126.00
667K
1
$116.96B
2024-08-01
2024-08-02
SACHS BRUCE
M - Exercise
Stock Option (Right to Buy)
-5,295
$0.00
1
$116.96B
2024-07-30
2024-08-01
KEWALRAMANI RESHMA
CEO & President
S - Sale
Common Stock
-15,202
$505.00
-7.68M
1
$116.96B
2024-07-24
2024-07-25
BOZIC CARMEN
EVP and CMO
S - Sale
Common Stock
-2,280
$488.00
-1.11M
1
$116.96B
2024-07-22
2024-07-24
KEWALRAMANI RESHMA
CEO & President
S - Sale
Common Stock
-15,202
$497.00
-7.56M
1
$116.96B
2024-07-15
2024-07-17
SACHS BRUCE
A - Grant
Deferred Stock Units
89
$490.00
43,610
1
$116.96B
2024-07-10
2024-07-12
BOZIC CARMEN
EVP and CMO
S - Sale
Common Stock
-2,280
$487.00
-1.11M
1
$116.96B
2024-06-26
2024-06-28
BOZIC CARMEN
EVP and CMO
S - Sale
Common Stock
-2,280
$472.00
-1.08M
1
$116.96B
2024-06-12
2024-06-13
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
S - Sale
Common Stock
-7,288
$478.00
-3.48M
1
$116.96B
2024-06-12
2024-06-13
BOZIC CARMEN
EVP and CMO
S - Sale
Common Stock
-2,280
$478.00
-1.09M
1
$116.96B
2024-06-11
2024-06-13
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
F - Tax
Common Stock
-6,824
$482.00
-3.29M
1
$116.96B
2024-06-05
2024-06-07
SACHDEV AMIT
EVP Chief Patient & Ext Af Off
G - Gift
Common Stock
-4,600
$0.00
1
$116.96B
2024-06-03
2024-06-05
WAGNER CHARLES JR
EVP & Chief Financial Officer
S - Sale
Common Stock
-3,250
$460.00
-1.50M
1
$116.96B
2024-06-03
2024-06-05
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
S - Sale
Common Stock
-2,175
$460.00
-1.00M
1
$116.96B
2024-05-31
2024-06-03
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
S - Sale
Common Stock
-2,250
$445.00
-1.00M
1
$116.96B
2024-05-30
2024-06-03
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
S - Sale
Common Stock
-2,350
$439.00
-1.03M
1
$116.96B
2024-05-29
2024-05-31
BOZIC CARMEN
EVP and CMO
S - Sale
Common Stock
-2,280
$446.00
-1.02M
1
$116.96B
2024-05-28
2024-05-30
WAGNER CHARLES JR
EVP & Chief Financial Officer
S - Sale
Common Stock
-3,250
$455.00
-1.48M
1
$116.96B
2024-05-24
2024-05-29
KEWALRAMANI RESHMA
CEO & President
S - Sale
Common Stock
-1,565
$457.00
-715K
1
$116.96B
2024-05-24
2024-05-29
KEWALRAMANI RESHMA
CEO & President
M - Exercise
Common Stock
1,565
$188.00
294K
1
$116.96B
2024-05-24
2024-05-29
KEWALRAMANI RESHMA
CEO & President
M - Exercise
Stock Option (Right to Buy)
-1,565
$0.00
1
$116.96B
2024-05-22
2024-05-24
SACHS BRUCE
S - Sale
Common Stock
-7,073
$448.00
-3.17M
1
$116.96B
2024-05-22
2024-05-24
SACHS BRUCE
M - Exercise
Common Stock
7,073
$94.00
665K
1
$116.96B
2024-05-22
2024-05-24
SACHS BRUCE
M - Exercise
Stock Option (Right to Buy)
-7,073
$0.00
1
$116.96B
2024-05-20
2024-05-22
KEWALRAMANI RESHMA
CEO & President
S - Sale
Common Stock
-15,202
$447.00
-6.80M
1
$116.96B
2024-05-15
2024-05-17
ARBUCKLE STUART
EVP, COO
S - Sale
Common Stock
-69
$431.00
-29,739
1
$116.96B
2024-05-15
2024-05-17
SCHNEIDER JENNIFER
A - Grant
Common Stock
922
$0.00
1
$116.96B
2024-05-15
2024-05-17
ALTSHULER DAVID
EVP, Chief Scientific Officer
S - Sale
Common Stock
-54
$431.00
-23,274
1
$116.96B
2024-05-15
2024-05-17
SACHDEV AMIT
EVP Chief Patient & Ext Af Off
S - Sale
Common Stock
-32
$431.00
-13,792
1
$116.96B
2024-05-14
2024-05-16
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
A - Grant
Common Stock
14,112
$0.00
1
$116.96B
2024-05-02
2024-05-03
BHATIA SANGEETA
S - Sale
Common Stock
-467
$403.00
-188K
1
$116.96B
2024-05-01
2024-05-03
MCKENZIE DIANA
D - Sale to Issuer
Common Stock
-1,168
1
$116.96B
2024-05-01
2024-05-03
UPADHYAY SUKETU
A - Grant
Common Stock
1,001
$0.00
1
$116.96B
2024-05-01
2024-05-03
UPADHYAY SUKETU
D - Sale to Issuer
Common Stock
-1,168
1
$116.96B
2024-05-01
2024-05-03
BHATIA SANGEETA
A - Grant
Common Stock
1,001
$0.00
1
$116.96B
2024-05-01
2024-05-03
UPADHYAY SUKETU
A - Grant
Deferred Stock Units
1,168
1
$116.96B
2024-05-01
2024-05-03
THORNBERRY NANCY
A - Grant
Stock Option (Right to Buy)
1,571
$0.00
1
$116.96B
2024-05-01
2024-05-03
THORNBERRY NANCY
A - Grant
Common Stock
501
$0.00
1
$116.96B
2024-05-01
2024-05-03
SACHS BRUCE
A - Grant
Stock Option (Right to Buy)
3,142
$0.00
1
$116.96B
2024-05-01
2024-05-03
MCKENZIE DIANA
A - Grant
Common Stock
1,001
$0.00
1
$116.96B
2024-05-01
2024-05-03
LAGARDE MICHEL
A - Grant
Stock Option (Right to Buy)
3,142
$0.00
1
$116.96B
2024-05-01
2024-05-03
MCKENZIE DIANA
A - Grant
Deferred Stock Units
1,168
1
$116.96B
2024-05-01
2024-05-03
KEARNEY TERRENCE
A - Grant
Stock Option (Right to Buy)
3,142
$0.00
1
$116.96B
2024-05-01
2024-05-03
GARBER ALAN
A - Grant
Stock Option (Right to Buy)
3,142
$0.00
1
$116.96B
2024-05-01
2024-05-03
CARNEY LLOYD
A - Grant
Common Stock
1,001
$0.00
1
$116.96B
2024-04-15
2024-04-17
SACHS BRUCE
A - Grant
Deferred Stock Units
109
$400.00
43,600
1
$116.96B
2024-04-02
2024-04-03
AMBROSE KRISTEN
SVP & Chief Accounting Officer
S - Sale
Common Stock
-240
$419.00
-101K
1
$116.96B
2024-04-01
2024-04-03
AMBROSE KRISTEN
SVP & Chief Accounting Officer
F - Tax
Common Stock
-225
$418.00
-94,050
1
$116.96B
2024-02-26
2024-02-27
SACHDEV AMIT
EVP Chief Patient & Ext Af Off
S - Sale
Common Stock
-3,004
$426.00
-1.28M
1
$116.96B
2024-02-26
2024-02-27
ARBUCKLE STUART
EVP, COO
S - Sale
Common Stock
-5,034
$426.00
-2.14M
1
$116.96B
2024-02-26
2024-02-27
AMBROSE KRISTEN
SVP & Chief Accounting Officer
S - Sale
Common Stock
-883
$426.00
-376K
1
$116.96B
2024-02-26
2024-02-27
ALTSHULER DAVID
EVP, Global Research and CSO
S - Sale
Common Stock
-4,239
$426.00
-1.81M
1
$116.96B
2024-02-26
2024-02-27
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
S - Sale
Common Stock
-883
$426.00
-376K
1
$116.96B
2024-02-26
2024-02-27
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
S - Sale
Common Stock
-354
$426.00
-151K
1
$116.96B
2024-02-23
2024-02-27
ALTSHULER DAVID
EVP, Global Research and CSO
F - Tax
Common Stock
-3,970
$432.00
-1.72M
1
$116.96B
2024-02-23
2024-02-27
BOZIC CARMEN
EVP and CMO
F - Tax
Common Stock
-3,309
$432.00
-1.43M
1
$116.96B
2024-02-23
2024-02-27
KEWALRAMANI RESHMA
CEO & President
F - Tax
Common Stock
-9,386
$432.00
-4.05M
1
$116.96B
2024-02-23
2024-02-27
ARBUCKLE STUART
EVP, COO
F - Tax
Common Stock
-4,714
$432.00
-2.04M
1
$116.96B
2024-02-23
2024-02-27
WAGNER CHARLES JR
EVP & Chief Financial Officer
F - Tax
Common Stock
-3,309
$432.00
-1.43M
1
$116.96B
2024-02-23
2024-02-27
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
F - Tax
Common Stock
-3,309
$432.00
-1.43M
1
$116.96B
2024-02-23
2024-02-27
AMBROSE KRISTEN
SVP & Chief Accounting Officer
F - Tax
Common Stock
-828
$432.00
-358K
1
$116.96B
2024-02-23
2024-02-27
SACHDEV AMIT
EVP Chief Patient & Ext Af Off
F - Tax
Common Stock
-2,469
$432.00
-1.07M
1
$116.96B
2024-02-23
2024-02-27
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
F - Tax
Common Stock
-1,654
$432.00
-715K
1
$116.96B
2024-02-26
2024-02-26
SANNA BASTIANO
EVP, Cell & Genetic Therapies
S - Sale
-4,239
$426.00
-1.81M
1
$116.96B
2024-02-21
2024-02-23
SACHDEV AMIT
EVP Chief Patient & Ext Af Off
S - Sale
Common Stock
-3,191
$422.00
-1.35M
1
$116.96B
2024-02-21
2024-02-23
ALTSHULER DAVID
EVP, Global Research and CSO
S - Sale
Common Stock
-3,002
$422.00
-1.27M
1
$116.96B
2024-02-21
2024-02-23
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
S - Sale
Common Stock
-1,201
$422.00
-507K
1
$116.96B
2024-02-21
2024-02-23
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
S - Sale
Common Stock
-360
$422.00
-152K
1
$116.96B
2024-02-21
2024-02-23
ARBUCKLE STUART
EVP, COO
S - Sale
Common Stock
-3,603
$422.00
-1.52M
1
$116.96B
2024-02-21
2024-02-21
SANNA BASTIANO
EVP, Cell & Genetic Therapies
S - Sale
-3,002
$422.00
-1.27M
1
$116.96B
2024-02-20
2024-02-21
WAGNER CHARLES JR
EVP & Chief Financial Officer
F - Tax
Common Stock
-2,812
$421.00
-1.18M
1
$116.96B
2024-02-20
2024-02-21
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
F - Tax
Common Stock
-3,373
$421.00
-1.42M
1
$116.96B
2024-02-20
2024-02-21
LEIDEN JEFFREY
Executive Chairman
F - Tax
Common Stock
-4,118
$421.00
-1.73M
1
$116.96B
2024-02-20
2024-02-21
SACHDEV AMIT
EVP Chief Patient & Ext Af Off
F - Tax
Common Stock
-2,623
$421.00
-1.10M
1
$116.96B
2024-02-20
2024-02-21
BOZIC CARMEN
EVP and CMO
F - Tax
Common Stock
-2,812
$421.00
-1.18M
1
$116.96B
2024-02-20
2024-02-21
KEWALRAMANI RESHMA
CEO & President
F - Tax
Common Stock
-7,019
$421.00
-2.95M
1
$116.96B
2024-02-20
2024-02-21
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
F - Tax
Common Stock
-1,125
$421.00
-474K
1
$116.96B
2024-02-20
2024-02-21
ARBUCKLE STUART
EVP, COO
F - Tax
Common Stock
-3,373
$421.00
-1.42M
1
$116.96B
2024-02-20
2024-02-21
ALTSHULER DAVID
EVP, Global Research and CSO
F - Tax
Common Stock
-2,812
$421.00
-1.18M
1
$116.96B
2024-02-20
2024-02-21
ALTSHULER DAVID
EVP, Global Research and CSO
S - Sale
Common Stock
-4,002
$421.00
-1.68M
1
$116.96B
2024-02-20
2024-02-21
ARBUCKLE STUART
EVP, COO
S - Sale
Common Stock
-4,804
$421.00
-2.02M
1
$116.96B
2024-02-20
2024-02-21
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
S - Sale
Common Stock
-480
$421.00
-202K
1
$116.96B
2024-02-20
2024-02-21
SACHDEV AMIT
EVP Chief Patient & Ext Af Off
S - Sale
Common Stock
-4,254
$421.00
-1.79M
1
$116.96B
2024-02-20
2024-02-21
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
S - Sale
Common Stock
-801
$421.00
-337K
1
$116.96B
2024-02-16
2024-02-21
ARBUCKLE STUART
EVP, COO
F - Tax
Common Stock
-4,499
$424.00
-1.91M
1
$116.96B
2024-02-16
2024-02-21
ALTSHULER DAVID
EVP, Global Research and CSO
F - Tax
Common Stock
-3,750
$424.00
-1.59M
1
$116.96B
2024-02-16
2024-02-21
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
F - Tax
Common Stock
-1,501
$424.00
-636K
1
$116.96B
2024-02-16
2024-02-21
WAGNER CHARLES JR
EVP & Chief Financial Officer
F - Tax
Common Stock
-3,750
$424.00
-1.59M
1
$116.96B
2024-02-16
2024-02-21
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
F - Tax
Common Stock
-4,499
$424.00
-1.91M
1
$116.96B
2024-02-16
2024-02-21
SACHDEV AMIT
EVP Chief Patient & Ext Af Off
F - Tax
Common Stock
-3,498
$424.00
-1.48M
1
$116.96B
2024-02-16
2024-02-21
BOZIC CARMEN
EVP and CMO
F - Tax
Common Stock
-3,750
$424.00
-1.59M
1
$116.96B
2024-02-16
2024-02-21
KEWALRAMANI RESHMA
CEO & President
F - Tax
Common Stock
-9,359
$424.00
-3.97M
1
$116.96B
2024-02-20
2024-02-20
SANNA BASTIANO
EVP, Cell & Genetic Therapies
S - Sale
-4,002
$421.00
-1.68M
1
$116.96B
2024-02-15
2024-02-16
LEIDEN JEFFREY
Executive Chairman
S - Sale
Common Stock
-4,655
$419.00
-1.95M
1
$116.96B
2024-02-14
2024-02-16
LEIDEN JEFFREY
Executive Chairman
S - Sale
Common Stock
-4,356
$419.00
-1.83M
1
$116.96B
2024-02-14
2024-02-14
SANNA BASTIANO
EVP, Cell & Genetic Therapies
S - Sale
-3,145
$419.00
-1.32M
1
$116.96B
2024-02-13
2024-02-14
LEIDEN JEFFREY
Executive Chairman
S - Sale
Common Stock
-737
$419.00
-309K
1
$116.96B
2024-02-12
2024-02-14
LEIDEN JEFFREY
Executive Chairman
S - Sale
Common Stock
-2,656
$420.00
-1.12M
2
$116.96B
2024-02-12
2024-02-13
SACHDEV AMIT
EVP Chief Patient & Ext Af Off
S - Sale
Common Stock
-3,222
$420.00
-1.35M
1
$116.96B
2024-02-12
2024-02-13
BILLER JONATHAN
EVP and Chief Legal Officer
S - Sale
Common Stock
-1,738
$419.00
-728K
1
$116.96B
2024-02-12
2024-02-13
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
S - Sale
Common Stock
-913
$420.00
-383K
1
$116.96B
2024-02-12
2024-02-13
ARBUCKLE STUART
EVP, COO
S - Sale
Common Stock
-4,295
$420.00
-1.80M
1
$116.96B
2024-02-12
2024-02-13
AMBROSE KRISTEN
SVP & Chief Accounting Officer
S - Sale
Common Stock
-1,374
$420.00
-577K
1
$116.96B
2024-02-12
2024-02-13
ALTSHULER DAVID
EVP, Global Research and CSO
S - Sale
Common Stock
-3,145
$420.00
-1.32M
1
$116.96B
2024-02-12
2024-02-13
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
S - Sale
Common Stock
-314
$420.00
-132K
1
$116.96B
2024-02-09
2024-02-13
AMBROSE KRISTEN
SVP & Chief Accounting Officer
F - Tax
Common Stock
-591
$423.00
-250K
1
$116.96B
2024-02-09
2024-02-13
ALTSHULER DAVID
EVP, Global Research and CSO
F - Tax
Common Stock
-2,099
$423.00
-888K
1
$116.96B
2024-02-09
2024-02-13
ARBUCKLE STUART
EVP, COO
F - Tax
Common Stock
-3,177
$423.00
-1.34M
1
$116.96B
2024-02-09
2024-02-13
WAGNER CHARLES JR
EVP & Chief Financial Officer
F - Tax
Common Stock
-2,607
$423.00
-1.10M
1
$116.96B
2024-02-09
2024-02-13
BILLER JONATHAN
EVP and Chief Legal Officer
F - Tax
Common Stock
-1,588
$423.00
-672K
1
$116.96B
2024-02-09
2024-02-13
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
F - Tax
Common Stock
-832
$423.00
-352K
1
$116.96B
2024-02-09
2024-02-13
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
F - Tax
Common Stock
-2,100
$423.00
-888K
1
$116.96B
2024-02-09
2024-02-13
SACHDEV AMIT
EVP Chief Patient & Ext Af Off
F - Tax
Common Stock
-2,022
$423.00
-855K
1
$116.96B
2024-02-09
2024-02-13
KEWALRAMANI RESHMA
CEO & President
F - Tax
Common Stock
-8,255
$423.00
-3.49M
1
$116.96B
2024-02-09
2024-02-13
BOZIC CARMEN
EVP and CMO
F - Tax
Common Stock
-2,100
$423.00
-888K
1
$116.96B
2024-02-09
2024-02-12
LEIDEN JEFFREY
Executive Chairman
F - Tax
Common Stock
-8,048
$423.00
-3.40M
1
$116.96B
2024-02-08
2024-02-12
LEIDEN JEFFREY
Executive Chairman
F - Tax
Common Stock
-2,698
$422.00
-1.14M
1
$116.96B
2024-02-07
2024-02-08
WAGNER CHARLES JR
EVP & Chief Financial Officer
A - Grant
Common Stock
7,114
$0.00
1
$116.96B
2024-02-07
2024-02-08
BOZIC CARMEN
EVP and CMO
A - Grant
Common Stock
5,928
$0.00
1
$116.96B
2024-02-07
2024-02-08
SACHDEV AMIT
EVP Chief Patient & Ext Af Off
A - Grant
Common Stock
7,114
$0.00
1
$116.96B
2024-02-07
2024-02-08
LEIDEN JEFFREY
Executive Chairman
A - Grant
Common Stock
7,707
$0.00
1
$116.96B
2024-02-07
2024-02-08
KEWALRAMANI RESHMA
CEO & President
A - Grant
Common Stock
20,327
$0.00
1
$116.96B
2024-02-07
2024-02-08
BILLER JONATHAN
EVP and Chief Legal Officer
A - Grant
Common Stock
4,743
$0.00
1
$116.96B
2024-02-07
2024-02-08
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
A - Grant
Common Stock
4,743
$0.00
1
$116.96B
2024-02-07
2024-02-08
ARBUCKLE STUART
EVP, COO
A - Grant
Common Stock
8,448
$0.00
1
$116.96B
2024-02-07
2024-02-08
AMBROSE KRISTEN
SVP & Chief Accounting Officer
A - Grant
Common Stock
1,853
$0.00
1
$116.96B
2024-02-07
2024-02-08
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
A - Grant
Common Stock
7,114
$0.00
1
$116.96B
2024-02-07
2024-02-08
ALTSHULER DAVID
EVP, Global Research and CSO
A - Grant
Common Stock
7,114
$0.00
1
$116.96B
2024-02-06
2024-02-08
ALTSHULER DAVID
EVP, Global Research and CSO
A - Grant
Common Stock
13,680
$0.00
2
$116.96B
2024-02-06
2024-02-08
ARBUCKLE STUART
EVP, COO
A - Grant
Common Stock
18,186
$0.00
2
$116.96B
2024-02-06
2024-02-08
AMBROSE KRISTEN
SVP & Chief Accounting Officer
A - Grant
Common Stock
2,950
$0.00
1
$116.96B
2024-02-06
2024-02-08
WAGNER CHARLES JR
EVP & Chief Financial Officer
A - Grant
Common Stock
15,254
$0.00
2
$116.96B
2024-02-06
2024-02-08
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
A - Grant
Common Stock
14,842
$0.00
2
$116.96B
2024-02-06
2024-02-08
SACHDEV AMIT
EVP Chief Patient & Ext Af Off
A - Grant
Common Stock
13,680
$0.00
2
$116.96B
2024-02-06
2024-02-08
LEIDEN JEFFREY
Executive Chairman
A - Grant
Common Stock
30,916
$0.00
2
$116.96B
2024-02-06
2024-02-08
KEWALRAMANI RESHMA
CEO & President
A - Grant
Common Stock
41,488
$0.00
2
$116.96B
2024-02-06
2024-02-08
BOZIC CARMEN
EVP and CMO
A - Grant
Common Stock
13,680
$0.00
2
$116.96B
2024-02-06
2024-02-08
BILLER JONATHAN
EVP and Chief Legal Officer
A - Grant
Common Stock
6,294
$0.00
1
$116.96B
2024-02-06
2024-02-08
ATKINSON EDWARD MORROW III
EVP, Chief Technical Ops. Off.
A - Grant
Common Stock
6,260
$0.00
2
$116.96B
2024-01-12
2024-01-17
SACHS BRUCE
A - Grant
Deferred Stock Units
101
$433.00
43,733
1
$116.96B
2024-01-12
2024-01-17
MCKENZIE DIANA
A - Grant
Deferred Stock Units
76
$433.00
32,908
1
$116.96B
2024-01-08
2024-01-10
LEIDEN JEFFREY
Executive Chairman
S - Sale
Common Stock
-6,648
$419.00
-2.79M
1
$116.96B
2024-01-02
2024-01-04
WAGNER CHARLES JR
EVP & Chief Financial Officer
S - Sale
Common Stock
-3,000
$405.00
-1.22M
1
$116.96B
2023-12-15
2023-12-19
KEWALRAMANI RESHMA
CEO & President
S - Sale
Common Stock
-17,135
$407.00
-6.97M
1
$116.96B
2023-12-15
2023-12-19
KEWALRAMANI RESHMA
CEO & President
M - Exercise
Stock Option (Right to Buy)
-17,135
$0.00
2
$116.96B
2023-12-15
2023-12-19
KEWALRAMANI RESHMA
CEO & President
M - Exercise
Common Stock
17,135
$182.00
3.12M
2
$116.96B
2023-12-13
2023-12-15
ARBUCKLE STUART
EVP, COO
S - Sale
Common Stock
-8,603
$399.00
-3.43M
1
$116.96B
2023-12-13
2023-12-15
ARBUCKLE STUART
EVP, COO
M - Exercise
Common Stock
8,603
$188.00
1.62M
1
$116.96B
2023-12-13
2023-12-15
ARBUCKLE STUART
EVP, COO
M - Exercise
Stock Option (Right to Buy)
-8,603
$0.00
1
$116.96B
2023-12-13
2023-12-15
LEIDEN JEFFREY
Executive Chairman
S - Sale
Common Stock
-13,354
$399.00
-5.33M
2
$116.96B
2023-12-13
2023-12-15
KEWALRAMANI RESHMA
CEO & President
S - Sale
Common Stock
-5,098
$397.00
-2.02M
1
$116.96B
2023-12-05
2023-12-06
THORNBERRY NANCY
A - Grant
Common Stock
1,136
$0.00
1
$116.96B
2023-11-20
2023-11-21
WAGNER CHARLES JR
EVP & Chief Financial Officer
S - Sale
Common Stock
-3,000
$350.00
-1.05M
1
$116.96B
2023-11-15
2023-11-17
ALTSHULER DAVID
EVP, Global Research and CSO
S - Sale
Common Stock
-19
$370.00
-7,030
1
$116.96B
2023-11-15
2023-11-17
SACHDEV AMIT
EVP Chief Patient & Ext Af Off
S - Sale
Common Stock
-35
$370.00
-12,950
1
$116.96B
2023-11-14
2023-11-16
BOZIC CARMEN
EVP and CMO
S - Sale
Common Stock
-5,650
$381.00
-2.15M
1
$116.96B
2023-11-13
2023-11-15
KEWALRAMANI RESHMA
CEO & President
S - Sale
Common Stock
-5,097
$377.00
-1.92M
1
$116.96B
2023-11-06
2023-11-08
SACHS BRUCE
M - Exercise
Common Stock
11,250
$128.00
1.44M
1
$116.96B
2023-11-06
2023-11-08
SACHS BRUCE
M - Exercise
Stock Option (Right to Buy)
-11,250
$0.00
1
$116.96B
2023-11-06
2023-11-08
SACHS BRUCE
S - Sale
Common Stock
-11,250
$385.00
-4.33M
1
$116.96B
2023-10-31
2023-11-02
BOZIC CARMEN
EVP and CMO
S - Sale
Common Stock
-5,651
$356.00
-2.01M
1
$116.96B
2023-10-17
2023-10-19
BHATIA SANGEETA
S - Sale
Common Stock
-243
$375.00
-91,125
1
$116.96B
2023-10-17
2023-10-19
BOZIC CARMEN
EVP and CMO
S - Sale
Common Stock
-5,651
$373.00
-2.11M
1
$116.96B
2023-10-16
2023-10-18
LEIDEN JEFFREY
Executive Chairman
S - Sale
Common Stock
-12,962
$374.00
-4.85M
1
$116.96B
2023-10-13
2023-10-17
SACHS BRUCE
A - Grant
Deferred Stock Units
118
$370.00
43,660
1
$116.96B
2023-10-13
2023-10-17
MCKENZIE DIANA
A - Grant
Deferred Stock Units
89
$370.00
32,930
1
$116.96B
2023-10-06
2023-10-11
BHATIA SANGEETA
S - Sale
Common Stock
-242
$360.00
-87,120
1
$116.96B
2023-10-05
2023-10-10
LAGARDE MICHEL
A - Grant
Common Stock
1,132
$0.00
1
$116.96B
2023-10-03
2023-10-05
BOZIC CARMEN
EVP and CMO
S - Sale
Common Stock
-5,651
$345.00
-1.95M
1
$116.96B
2023-10-02
2023-10-03
BILLER JONATHAN
EVP and Chief Legal Officer
S - Sale
Common Stock
-610
$347.00
-212K
1
$116.96B
2023-09-29
2023-10-03
BILLER JONATHAN
EVP and Chief Legal Officer
F - Tax
Common Stock
-408
$351.00
-143K
1
$116.96B
2023-09-19
2023-09-21
BOZIC CARMEN
EVP and CMO
S - Sale
Common Stock
-5,651
$351.00
-1.98M
1
$116.96B
2023-09-05
2023-09-07
BOZIC CARMEN
EVP and CMO
S - Sale
Common Stock
-5,651
$353.00
-1.99M
1
$116.96B
2023-08-23
2023-08-25
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
S - Sale
Common Stock
-2,500
$355.00
-888K
1
$116.96B
2023-08-10
2023-08-14
SACHDEV AMIT
EVP, Chief Patient Officer
S - Sale
Common Stock
-10,031
$350.00
-3.51M
1
$116.96B
2023-08-10
2023-08-14
KEARNEY TERRENCE
S - Sale
Common Stock
-10,000
$350.00
-3.50M
1
$116.96B
2023-08-10
2023-08-14
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
S - Sale
Common Stock
-5,750
$346.00
-1.99M
1
$116.96B
2023-08-10
2023-08-14
KEARNEY TERRENCE
M - Exercise
Common Stock
10,000
$128.00
1.28M
1
$116.96B
2023-08-10
2023-08-14
KEARNEY TERRENCE
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
1
$116.96B
2023-08-09
2023-08-11
BHATIA SANGEETA
S - Sale
Common Stock
-242
$346.00
-83,732
1
$116.96B
2023-08-09
2023-08-11
ALTSHULER DAVID
EVP, Global Research and CSO
S - Sale
Common Stock
-63
$346.00
-21,798
1
$116.96B
2023-07-17
2023-07-18
SACHS BRUCE
M - Exercise
Common Stock
11,250
$128.00
1.44M
1
$116.96B
2023-07-17
2023-07-18
SACHS BRUCE
M - Exercise
Stock Option (Right to Buy)
-11,250
$0.00
1
$116.96B
2023-07-17
2023-07-18
KEWALRAMANI RESHMA
CEO & President
S - Sale
Common Stock
-7,828
$355.00
-2.78M
1
$116.96B
2023-07-17
2023-07-18
SACHS BRUCE
S - Sale
Common Stock
-11,250
$357.00
-4.02M
3
$116.96B
2023-07-14
2023-07-18
SACHS BRUCE
A - Grant
Deferred Stock Units
124
$351.00
43,524
1
$116.96B
2023-07-14
2023-07-18
MCKENZIE DIANA
A - Grant
Deferred Stock Units
89
$351.00
31,239
1
$116.96B
2023-06-15
2023-06-20
ARBUCKLE STUART
EVP, COO
S - Sale
Common Stock
-8,603
$349.00
-3.00M
1
$116.96B
2023-06-15
2023-06-20
ARBUCKLE STUART
EVP, COO
M - Exercise
Stock Option (Right to Buy)
-8,603
$0.00
1
$116.96B
2023-06-15
2023-06-20
ARBUCKLE STUART
EVP, COO
M - Exercise
Common Stock
8,603
$188.00
1.62M
1
$116.96B
2023-05-30
2023-06-01
ARBUCKLE STUART
EVP, COO
S - Sale
Common Stock
-82
$330.00
-27,060
1
$116.96B
2023-05-30
2023-06-01
AMBROSE KRISTEN
SVP & Chief Accounting Officer
S - Sale
Common Stock
-289
$330.00
-95,370
1
$116.96B
2023-05-08
2023-05-09
LEIDEN JEFFREY
Executive Chairman
S - Sale
Common Stock
-1,125
$349.00
-393K
1
$116.96B
2023-05-08
2023-05-09
SANNA BASTIANO
EVP, Cell & Genetic Therapies
S - Sale
Common Stock
-2,850
$350.00
-998K
1
$116.96B
2023-05-05
2023-05-09
SANNA BASTIANO
EVP, Cell & Genetic Therapies
S - Sale
Common Stock
-422
$350.00
-148K
1
$116.96B
2023-05-05
2023-05-09
LEIDEN JEFFREY
Executive Chairman
S - Sale
Common Stock
-879
$350.00
-308K
2
$116.96B
2023-05-03
2023-05-04
SANNA BASTIANO
EVP, Cell & Genetic Therapies
S - Sale
Common Stock
-2,781
$351.00
-976K
2
$116.96B
2023-05-03
2023-05-04
LEIDEN JEFFREY
Executive Chairman
S - Sale
Common Stock
-4,508
$350.00
-1.58M
3
$116.96B
2023-05-02
2023-05-04
LEIDEN JEFFREY
Executive Chairman
S - Sale
Common Stock
-6,450
$350.00
-2.26M
3
$116.96B
2023-05-02
2023-05-04
SANNA BASTIANO
EVP, Cell & Genetic Therapies
S - Sale
Common Stock
-1,622
$351.00
-569K
3
$116.96B
2023-05-02
2023-05-03
BHATIA SANGEETA
S - Sale
Common Stock
-580
$348.00
-202K
5
$116.96B
2023-05-01
2023-05-03
GARBER ALAN
A - Grant
Stock Option (Right to Buy)
1,741
$0.00
1
$116.96B
2023-05-01
2023-05-03
KEARNEY TERRENCE
A - Grant
Stock Option (Right to Buy)
3,481
$0.00
1
$116.96B
2023-05-01
2023-05-03
CARNEY LLOYD
A - Grant
Common Stock
1,168
$0.00
1
$116.96B
2023-05-01
2023-05-03
UPADHYAY SUKETU
A - Grant
Common Stock
1,168
$0.00
1
$116.96B
2023-05-01
2023-05-03
SACHS BRUCE
A - Grant
Stock Option (Right to Buy)
3,481
$0.00
1
$116.96B
2023-05-01
2023-05-03
BHATIA SANGEETA
A - Grant
Common Stock
1,168
$0.00
1
$116.96B
2023-05-01
2023-05-03
MCKENZIE DIANA
A - Grant
Common Stock
1,168
$0.00
1
$116.96B
2023-05-01
2023-05-03
MCKENZIE DIANA
A - Grant
Deferred Stock Units
1,449
1
$116.96B
2023-05-01
2023-05-03
MCGLYNN MARGARET
A - Grant
Stock Option (Right to Buy)
3,481
$0.00
1
$116.96B
2023-05-01
2023-05-03
LEE YUCHUN
A - Grant
Stock Option (Right to Buy)
3,481
$0.00
1
$116.96B
2023-05-01
2023-05-03
GARBER ALAN
A - Grant
Common Stock
584
$0.00
1
$116.96B
2023-05-01
2023-05-03
MCKENZIE DIANA
D - Sale to Issuer
Common Stock
-1,449
1
$116.96B
2023-04-27
2023-05-01
KEWALRAMANI RESHMA
CEO & President
S - Sale
Common Stock
-3,317
$339.00
-1.12M
3
$116.96B
2023-04-14
2023-04-18
SACHS BRUCE
A - Grant
Deferred Stock Units
131
$333.00
43,623
1
$116.96B
2023-04-14
2023-04-18
MCKENZIE DIANA
A - Grant
Deferred Stock Units
90
$333.00
29,970
1
$116.96B
2023-04-13
2023-04-14
SACHS BRUCE
G - Gift
Common Stock
-1,210
$0.00
1
$116.96B
2023-04-12
2023-04-14
SACHS BRUCE
M - Exercise
Stock Option (Right to Buy)
-21,300
$0.00
1
$116.96B
2023-04-12
2023-04-14
SANNA BASTIANO
EVP, Cell & Genetic Therapies
S - Sale
Common Stock
-7,567
$327.00
-2.47M
3
$116.96B
2023-04-12
2023-04-14
SACHS BRUCE
S - Sale
Common Stock
-21,300
$327.00
-6.97M
3
$116.96B
2023-04-12
2023-04-14
SACHS BRUCE
M - Exercise
Common Stock
21,300
$72.00
1.53M
1
$116.96B
2023-04-04
2023-04-06
SANNA BASTIANO
EVP, Cell & Genetic Therapies
S - Sale
Common Stock
-522
$316.00
-165K
5
$116.96B
2023-03-31
2023-04-04
SANNA BASTIANO
EVP, Cell & Genetic Therapies
F - Tax
Common Stock
-1,466
$314.00
-460K
1
$116.96B
2023-03-31
2023-04-04
AMBROSE KRISTEN
SVP & Chief Accounting Officer
F - Tax
Common Stock
-176
$314.00
-55,264
1
$116.96B
2023-03-24
2023-03-28
WAGNER CHARLES JR
EVP & Chief Financial Officer
S - Sale
Common Stock
-1,768
$305.00
-539K
1
$116.96B
2023-03-17
2023-03-21
WAGNER CHARLES JR
EVP & Chief Financial Officer
S - Sale
Common Stock
-2,000
$296.00
-592K
6
$116.96B
2023-03-16
2023-03-20
SANNA BASTIANO
EVP, Cell & Genetic Therapies
S - Sale
Common Stock
-2,746
$301.00
-827K
2
$116.96B
2023-03-13
2023-03-14
WAGNER CHARLES JR
EVP & Chief Financial Officer
S - Sale
Common Stock
-2,666
$294.00
-784K
6
$116.96B
2023-03-10
2023-03-14
WAGNER CHARLES JR
EVP & Chief Financial Officer
S - Sale
Common Stock
-2,088
$290.00
-606K
8
$116.96B
2023-02-27
2023-02-28
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
S - Sale
Common Stock
-354
$287.00
-102K
3
$116.96B
2023-02-27
2023-02-28
ARBUCKLE STUART
EVP, COO
S - Sale
Common Stock
-5,034
$287.00
-1.44M
3
$116.96B
2023-02-27
2023-02-28
AMBROSE KRISTEN
SVP & Chief Accounting Officer
S - Sale
Common Stock
-1,207
$288.00
-348K
3
$116.96B
2023-02-27
2023-02-28
ALTSHULER DAVID
EVP, Global Research and CSO
S - Sale
Common Stock
-4,238
$288.00
-1.22M
3
$116.96B
2023-02-24
2023-02-28
AMBROSE KRISTEN
SVP & Chief Accounting Officer
F - Tax
Common Stock
-502
$289.00
-145K
1
$116.96B
2023-02-24
2023-02-28
ALTSHULER DAVID
EVP, Global Research and CSO
F - Tax
Common Stock
-3,970
$289.00
-1.15M
1
$116.96B
2023-02-24
2023-02-28
ARBUCKLE STUART
EVP, COO
F - Tax
Common Stock
-4,714
$289.00
-1.36M
1
$116.96B
2023-02-24
2023-02-28
WAGNER CHARLES JR
EVP & Chief Financial Officer
F - Tax
Common Stock
-3,308
$289.00
-956K
1
$116.96B
2023-02-24
2023-02-28
KEWALRAMANI RESHMA
CEO & President
F - Tax
Common Stock
-9,386
$289.00
-2.71M
1
$116.96B
2023-02-24
2023-02-28
BOZIC CARMEN
EVP and CMO
F - Tax
Common Stock
-3,308
$289.00
-956K
1
$116.96B
2023-02-24
2023-02-28
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
F - Tax
Common Stock
-3,308
$289.00
-956K
1
$116.96B
2023-02-24
2023-02-28
SANNA BASTIANO
EVP, Cell & Genetic Therapies
F - Tax
Common Stock
-3,970
$289.00
-1.15M
1
$116.96B
2023-02-24
2023-02-28
SACHDEV AMIT
EVP, Chief Patient Officer
F - Tax
Common Stock
-2,468
$289.00
-713K
1
$116.96B
2023-02-24
2023-02-28
LEIDEN JEFFREY
Executive Chairman
F - Tax
Common Stock
-13,730
$289.00
-3.97M
1
$116.96B
2023-02-22
2023-02-24
ARBUCKLE STUART
EVP, COO
S - Sale
Common Stock
-2,401
$294.00
-706K
5
$116.96B
2023-02-21
2023-02-22
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
S - Sale
Common Stock
-480
$294.00
-141K
4
$116.96B
2023-02-21
2023-02-22
ARBUCKLE STUART
EVP, COO
S - Sale
Common Stock
-2,402
$294.00
-706K
4
$116.96B
2023-02-21
2023-02-22
ALTSHULER DAVID
EVP, Global Research and CSO
S - Sale
Common Stock
-4,002
$294.00
-1.18M
4
$116.96B
2023-02-17
2023-02-22
ARBUCKLE STUART
EVP, COO
F - Tax
Common Stock
-4,498
$293.00
-1.32M
1
$116.96B
2023-02-17
2023-02-22
ALTSHULER DAVID
EVP, Global Research and CSO
F - Tax
Common Stock
-3,750
$293.00
-1.10M
1
$116.96B
2023-02-17
2023-02-22
WAGNER CHARLES JR
EVP & Chief Financial Officer
F - Tax
Common Stock
-3,750
$293.00
-1.10M
1
$116.96B
2023-02-17
2023-02-22
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
F - Tax
Common Stock
-4,498
$293.00
-1.32M
1
$116.96B
2023-02-17
2023-02-22
KEWALRAMANI RESHMA
CEO & President
F - Tax
Common Stock
-9,359
$293.00
-2.74M
1
$116.96B
2023-02-17
2023-02-22
BOZIC CARMEN
EVP and CMO
F - Tax
Common Stock
-3,750
$293.00
-1.10M
1
$116.96B
2023-02-17
2023-02-22
SANNA BASTIANO
EVP, Cell & Genetic Therapies
F - Tax
Common Stock
-3,750
$293.00
-1.10M
1
$116.96B
2023-02-17
2023-02-22
SACHDEV AMIT
EVP, Chief Patient Officer
F - Tax
Common Stock
-3,498
$293.00
-1.02M
1
$116.96B
2023-02-14
2023-02-16
ARBUCKLE STUART
EVP, COO
S - Sale
Common Stock
-6,398
$299.00
-1.91M
6
$116.96B
2023-02-14
2023-02-16
ALTSHULER DAVID
EVP, Global Research and CSO
S - Sale
Common Stock
-6,398
$299.00
-1.91M
6
$116.96B
2023-02-14
2023-02-16
SANNA BASTIANO
EVP, Cell & Genetic Therapies
S - Sale
Common Stock
-2,181
$300.00
-654K
2
$116.96B
2023-02-14
2023-02-16
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
S - Sale
Common Stock
-320
$299.00
-95,680
5
$116.96B
2023-02-13
2023-02-14
KEWALRAMANI RESHMA
CEO & President
F - Tax
Common Stock
-5,990
$298.00
-1.79M
1
$116.96B
2023-02-13
2023-02-14
WAGNER CHARLES JR
EVP & Chief Financial Officer
F - Tax
Common Stock
-4,992
$298.00
-1.49M
1
$116.96B
2023-02-13
2023-02-14
SANNA BASTIANO
EVP, Cell & Genetic Therapies
F - Tax
Common Stock
-4,340
$298.00
-1.29M
1
$116.96B
2023-02-13
2023-02-14
SACHDEV AMIT
EVP, Chief Patient Officer
F - Tax
Common Stock
-4,657
$298.00
-1.39M
1
$116.96B
2023-02-13
2023-02-14
LEIDEN JEFFREY
Executive Chairman
F - Tax
Common Stock
-13,344
$298.00
-3.98M
1
$116.96B
2023-02-13
2023-02-14
BOZIC CARMEN
EVP and CMO
F - Tax
Common Stock
-4,992
$298.00
-1.49M
1
$116.96B
2023-02-13
2023-02-14
ARBUCKLE STUART
EVP, COO
F - Tax
Common Stock
-5,990
$298.00
-1.79M
1
$116.96B
2023-02-13
2023-02-14
ALTSHULER DAVID
EVP, Global Research and CSO
F - Tax
Common Stock
-5,990
$298.00
-1.79M
1
$116.96B
2023-02-13
2023-02-14
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
F - Tax
Common Stock
-2,995
$298.00
-893K
1
$116.96B
2023-02-13
2023-02-14
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
S - Sale
Common Stock
-275
$299.00
-82,225
5
$116.96B
2023-02-13
2023-02-14
SANNA BASTIANO
EVP, Cell & Genetic Therapies
S - Sale
Common Stock
-113
$300.00
-33,900
1
$116.96B
2023-02-13
2023-02-14
ARBUCKLE STUART
EVP, COO
S - Sale
Common Stock
-4,887
$299.00
-1.46M
4
$116.96B
2023-02-13
2023-02-14
ALTSHULER DAVID
EVP, Global Research and CSO
S - Sale
Common Stock
-4,798
$299.00
-1.43M
4
$116.96B
2023-02-10
2023-02-14
ARBUCKLE STUART
EVP, COO
F - Tax
Common Stock
-3,372
$294.00
-991K
1
$116.96B
2023-02-10
2023-02-14
ALTSHULER DAVID
EVP, Global Research and CSO
F - Tax
Common Stock
-3,461
$294.00
-1.02M
1
$116.96B
2023-02-10
2023-02-14
SACHDEV AMIT
EVP, Chief Patient Officer
F - Tax
Common Stock
-2,611
$294.00
-768K
1
$116.96B
2023-02-10
2023-02-14
KEWALRAMANI RESHMA
CEO & President
F - Tax
Common Stock
-3,372
$294.00
-991K
1
$116.96B
2023-02-10
2023-02-14
WAGNER CHARLES JR
EVP & Chief Financial Officer
F - Tax
Common Stock
-2,707
$294.00
-796K
1
$116.96B
2023-02-10
2023-02-14
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
F - Tax
Common Stock
-1,377
$294.00
-405K
1
$116.96B
2023-02-10
2023-02-14
SANNA BASTIANO
EVP, Cell & Genetic Therapies
F - Tax
Common Stock
-902
$294.00
-265K
1
$116.96B
2023-02-10
2023-02-14
BOZIC CARMEN
EVP and CMO
F - Tax
Common Stock
-2,707
$294.00
-796K
1
$116.96B
2023-02-06
2023-02-08
ALTSHULER DAVID
EVP, Global Research and CSO
M - Exercise
Stock Option (Right to Buy)
-1,304
$0.00
1
$116.96B
2023-02-06
2023-02-08
ALTSHULER DAVID
EVP, Global Research and CSO
S - Sale
Common Stock
-1,304
$306.00
-399K
6
$116.96B
2023-02-06
2023-02-08
ALTSHULER DAVID
EVP, Global Research and CSO
M - Exercise
Common Stock
1,304
$188.00
245K
1
$116.96B
2023-02-02
2023-02-03
LEIDEN JEFFREY
Executive Chairman
F - Tax
Common Stock
-3,578
$318.00
-1.14M
1
$116.96B
2023-02-01
2023-02-03
KEWALRAMANI RESHMA
CEO & President
A - Grant
Common Stock
68,478
$0.00
3
$116.96B
2023-02-01
2023-02-03
WAGNER CHARLES JR
EVP & Chief Financial Officer
A - Grant
Common Stock
30,026
$0.00
3
$116.96B
2023-02-01
2023-02-03
BILLER JONATHAN
EVP and Chief Legal Officer
A - Grant
Common Stock
6,293
$0.00
1
$116.96B
2023-02-01
2023-02-03
SANNA BASTIANO
EVP, Cell & Genetic Therapies
A - Grant
Common Stock
29,272
$0.00
3
$116.96B
2023-02-01
2023-02-03
SACHDEV AMIT
EVP, Chief Patient Officer
A - Grant
Common Stock
26,400
$0.00
3
$116.96B
2023-02-01
2023-02-03
LEIDEN JEFFREY
Executive Chairman
A - Grant
Common Stock
76,578
$0.00
3
$116.96B
2023-02-01
2023-02-03
ARBUCKLE STUART
EVP, COO
A - Grant
Common Stock
38,221
$0.00
3
$116.96B
2023-02-01
2023-02-03
BOZIC CARMEN
EVP and CMO
A - Grant
Common Stock
28,452
$0.00
3
$116.96B
2023-02-01
2023-02-03
AMBROSE KRISTEN
SVP & Chief Accounting Officer
A - Grant
Common Stock
5,516
$0.00
2
$116.96B
2023-02-01
2023-02-03
ALTSHULER DAVID
EVP, Global Research and CSO
A - Grant
Common Stock
32,568
$0.00
3
$116.96B
2023-02-01
2023-02-03
TATSIS OURANIA
EVP, Chief Reg. & Quality Off.
A - Grant
Common Stock
24,322
$0.00
3
$116.96B
2022-05-17
2023-02-03
SACHDEV AMIT
EVP, Chief Patient Officer
G - Gift
Common Stock
-1,672
$0.00
1
$116.96B
2023-01-31
2023-02-02
SANNA BASTIANO
EVP, Cell & Genetic Therapies
S - Sale
Common Stock
-106
$325.00
-34,450
1
$116.96B
2023-01-31
2023-02-02
SACHS BRUCE
M - Exercise
Common Stock
1,200
$72.00
86,400
1
$116.96B
2023-01-31
2023-02-02
SACHS BRUCE
S - Sale
Common Stock
-1,200
$325.00
-390K
1
$116.96B
2023-01-31
2023-02-02
SACHS BRUCE
M - Exercise
Stock Option (Right to Buy)
-1,200
$0.00
1
$116.96B
2023-01-30
2023-01-31
CARNEY LLOYD
S - Sale
Common Stock
-2,700
$321.00
-867K
3
$116.96B
2023-01-27
2023-01-31
LEE YUCHUN
M - Exercise
Stock Option (Right to Buy)
-1,429
$0.00
1
$116.96B
2023-01-27
2023-01-31
LEE YUCHUN
S - Sale
Common Stock
-1,429
$322.00
-460K
3
$116.96B
2023-01-27
2023-01-31
LEE YUCHUN
M - Exercise
Common Stock
1,429
$72.00
103K
1
$116.96B
2023-01-26
2023-01-27
LEE YUCHUN
S - Sale
Common Stock
-4,000
$318.00
-1.27M
6
$116.96B
2023-01-26
2023-01-27
LEE YUCHUN
M - Exercise
Common Stock
4,000
$72.00
288K
1
$116.96B
2023-01-26
2023-01-27
LEE YUCHUN
M - Exercise
Stock Option (Right to Buy)
-4,000
$0.00
1
$116.96B
2023-01-25
2023-01-27
LEE YUCHUN
M - Exercise
Stock Option (Right to Buy)
-4,000
$0.00
1
$116.96B
2023-01-25
2023-01-27
LEE YUCHUN
S - Sale
Common Stock
-4,000
$314.00
-1.26M
3
$116.96B
2023-01-25
2023-01-27
KEWALRAMANI RESHMA
CEO & President
S - Sale
Common Stock
-10,000
$315.00
-3.15M
1
$116.96B
2023-01-25
2023-01-27
LEE YUCHUN
M - Exercise
Common Stock
4,000
$72.00
288K
1
$116.96B
2023-01-24
2023-01-25
LEE YUCHUN
S - Sale
Common Stock
-4,000
$313.00
-1.25M
2
$116.96B
2023-01-24
2023-01-25
LEE YUCHUN
M - Exercise
Stock Option (Right to Buy)
-4,000
$0.00
1
$116.96B
2023-01-24
2023-01-25
LEE YUCHUN
M - Exercise
Common Stock
4,000
$72.00
288K
1
$116.96B
2023-01-23
2023-01-25
LEE YUCHUN
S - Sale
Common Stock
-2,129
$312.00
-664K
1
$116.96B
2023-01-23
2023-01-25
LEE YUCHUN
M - Exercise
Common Stock
2,129
$72.00
153K
1
$116.96B
2023-01-23
2023-01-25
LEE YUCHUN
M - Exercise
Stock Option (Right to Buy)
-2,129
$0.00
1
$116.96B
2023-01-18
2023-01-19
LEE YUCHUN
M - Exercise
Stock Option (Right to Buy)
-442
$0.00
1
$116.96B
2023-01-18
2023-01-19
LEE YUCHUN
S - Sale
Common Stock
-442
$312.00
-138K
1
$116.96B
2023-01-18
2023-01-19
LEE YUCHUN
M - Exercise
Common Stock
442
$72.00
31,824
1
$116.96B
2023-01-17
2023-01-19
LEE YUCHUN
S - Sale
Common Stock
-4,000
$312.00
-1.25M
1
$116.96B
2023-01-17
2023-01-19
LEE YUCHUN
M - Exercise
Common Stock
4,000
$72.00
288K
1
$116.96B
2023-01-17
2023-01-19
LEE YUCHUN
M - Exercise
Stock Option (Right to Buy)
-4,000
$0.00
1
$116.96B
2023-01-13
2023-01-18
UPADHYAY SUKETU
A - Grant
Deferred Stock Units
96
$298.00
28,608
1
$116.96B
2023-01-13
2023-01-18
SACHS BRUCE
A - Grant
Deferred Stock Units
146
$298.00
43,508
1
$116.96B
2023-01-13
2023-01-18
MCKENZIE DIANA
A - Grant
Deferred Stock Units
100
$298.00
29,800
1
$116.96B
2022-12-06
2022-12-08
ARBUCKLE STUART
EVP, COO
A - Grant
Common Stock
12,753
$0.00
1
$116.96B
2022-11-15
2022-11-17
ALTSHULER DAVID
EVP, Global Research and CSO
S - Sale
Common Stock
-34
$309.00
-10,506
1
$116.96B
2022-11-07
2022-11-09
ALTSHULER DAVID
EVP, Global Research and CSO
M - Exercise
Stock Option (Right to Buy)
-1,303
$0.00
1
$116.96B
2022-11-07
2022-11-09
ALTSHULER DAVID
EVP, Global Research and CSO
S - Sale
Common Stock
-1,303
$303.00
-395K
7
$116.96B
2022-11-07
2022-11-09
ALTSHULER DAVID
EVP, Global Research and CSO
M - Exercise
Common Stock
1,303
$188.00
245K
1
$116.96B
2022-11-02
2022-11-03
SANNA BASTIANO
EVP, Cell & Genetic Therapies
S - Sale
Common Stock
-320
$313.00
-100K
7
$116.96B
2022-11-01
2022-11-03
SANNA BASTIANO
EVP, Cell & Genetic Therapies
F - Tax
Common Stock
-768
$313.00
-240K
1
$116.96B
2022-10-24
2022-10-26
BHATIA SANGEETA
S - Sale
Common Stock
-621
$310.00
-193K
1
$116.96B
2022-10-18
2022-10-20
SANNA BASTIANO
EVP, Cell & Genetic Therapies
S - Sale
Common Stock
-1,791
$300.00
-537K
2
$116.96B
2022-10-14
2022-10-18
MCKENZIE DIANA
A - Grant
Deferred Stock Units
101
$297.00
29,997
1
$116.96B
2022-10-14
2022-10-18
SACHS BRUCE
A - Grant
Deferred Stock Units
147
$297.00
43,659
1
$116.96B
2022-10-14
2022-10-18
UPADHYAY SUKETU
A - Grant
Deferred Stock Units
96
$297.00
28,512
1
$116.96B
2022-09-19
2022-09-21
BILLER JONATHAN
EVP and Chief Legal Officer
A - Grant
Common Stock
5,294
$0.00
1
$116.96B
2022-08-15
2022-08-17
ARBUCKLE STUART
EVP, COO
S - Sale
Common Stock
-22,173
$304.00
-6.74M
6
$116.96B
2022-08-15
2022-08-17
KEWALRAMANI RESHMA
CEO & President
S - Sale
Common Stock
-11,689
$305.00
-3.57M
1
$116.96B
2022-08-15
2022-08-17
ARBUCKLE STUART
EVP, COO
M - Exercise
Common Stock
6,571
$156.00
1.03M
1
$116.96B
2022-08-15
2022-08-17
ARBUCKLE STUART
EVP, COO
M - Exercise
Stock Option (Right to Buy)
-6,571
$0.00
1
$116.96B
2022-08-15
2022-08-17
LIU JOY
SVP, General Counsel
S - Sale
Common Stock
-3,747
$304.00
-1.14M
6
$116.96B
2022-08-10
2022-08-12
ARBUCKLE STUART
EVP, COO
M - Exercise
Common Stock
64
$156.00
9,984
1
$116.96B
2022-08-10
2022-08-12
ARBUCKLE STUART
EVP, COO
M - Exercise
Stock Option (Right to Buy)
-64
$0.00
1
$116.96B
2022-08-10
2022-08-12
LIU JOY
SVP, General Counsel
S - Sale
Common Stock
-36
$300.00
-10,800
1
$116.96B
2022-08-10
2022-08-12
ARBUCKLE STUART
EVP, COO
S - Sale
Common Stock
-180
$300.00
-54,000
2
$116.96B
2022-08-09
2022-08-10
ARBUCKLE STUART
EVP, COO
M - Exercise
Common Stock
1,926
$156.00
300K
1
$116.96B
2022-08-09
2022-08-10
ARBUCKLE STUART
EVP, COO
M - Exercise
Stock Option (Right to Buy)
-1,926
$0.00
1
$116.96B
2022-08-09
2022-08-10
ARBUCKLE STUART
EVP, COO
S - Sale
Common Stock
-5,690
$301.00
-1.71M
2
$116.96B